β¨ Medicine Consent Notices
7 FEBRUARY 2013 NEW ZEALAND GAZETTE, No. 13 449
Product: Adacel Polio
Active Ingredients:
- Diphtheria toxoid, adsorbed 2IU
- Pertactin 3mcg
- Pertussis filamentous haemagglutinin 5mcg
- Pertussis fimbriae 2+3 5mcg
- Pertussis toxoid, adsorbed 2.5mcg
- Polio virus type 1 40DAgU
- Polio virus type 2 8DAgU
- Polio virus type 3 32DAgU
- Tetanus toxoid 20IU
Dosage Form: Suspension for injection
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: - Sanofi Pasteur SA, Marcy LβEtoile, France
- Sanofi Pasteur Limited, Ontario, Canada
Product: Pediacel
Active Ingredients:
- Diphtheria toxoid, adsorbed 15Lf U
- Haemophilus influenzae type b polysaccharide 10mcg
- Pertactin 3mcg
- Pertussis filamentous haemagglutinin 20mcg
- Pertussis fimbriae 2+3 5mcg
- Pertussis toxoid, adsorbed 20mcg
- Polio virus type 1 40DAgU
- Polio virus type 2 8DAgU
- Polio virus type 3 32DAgU
- Tetanus toxoid 20mcg
- Tetanus toxoid, adsorbed 5Lf U
Dosage Form: Suspension for injection
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Sanofi Pasteur Limited, Ontario, Canada
Product: Poliacel (Combination Product)
Active Ingredients:
- Diphtheria toxoid, adsorbed 15Lf U
- Pertactin 3mcg
- Pertussis filamentous haemagglutinin 20mcg
- Pertussis fimbriae 2+3 5mcg
- Pertussis toxoid, adsorbed 20mcg
- Polio virus type 1 40DAgU
- Polio virus type 2 8DAgU
- Polio virus type 3 32DAgU
- Tetanus toxoid, adsorbed 5Lf U
Dosage Form: Quadracel component Suspension for injection
Active Ingredient: Haemophilus influenzae type b polysaccharide 10mcg
Dosage Form: Act-HIB component Powder for injection
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Sanofi Pasteur Limited, Ontario, Canada
Product: Quadracel
Active Ingredients:
- Diphtheria toxoid, adsorbed 15Lf U
- Pertactin 3mcg
- Pertussis filamentous haemagglutinin 20mcg
- Pertussis fimbriae 2+3 5mcg
- Pertussis toxoid, adsorbed 20mcg
- Polio virus type 1 40DAgU
- Polio virus type 2 8DAgU
- Polio virus type 3 32DAgU
- Tetanus toxoid, adsorbed 5Lf U
Dosage Form: Suspension for injection
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Sanofi Pasteur Limited, Ontario, Canada
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare31 January 2013
Medicines Act 1981, New Medicine Consent, Adacel Polio, Vaccine
π₯ Consent to the Distribution of Pediacel
π₯ Health & Social Welfare31 January 2013
Medicines Act 1981, New Medicine Consent, Pediacel, Vaccine
π₯ Consent to the Distribution of Poliacel
π₯ Health & Social Welfare31 January 2013
Medicines Act 1981, New Medicine Consent, Poliacel, Vaccine
π₯ Consent to the Distribution of Quadracel
π₯ Health & Social Welfare31 January 2013
Medicines Act 1981, New Medicine Consent, Quadracel, Vaccine
NZ Gazette 2013, No 13